World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 May 2015
Main ID:  NCT02432885
Date of registration: 24/03/2015
Prospective Registration: No
Primary sponsor: InCor Heart Institute
Public title: Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial
Scientific title: Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy
Date of first enrolment: June 2009
Target sample size: 76
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02432885
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
Contacts
Name:     Carlos E Rochitte, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  InCor, Heart Institute, University of Sao Paulo Medical School
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with biopsy-proven Muscular Dystrophy of Duchenne or Becker

Exclusion Criteria:

- Contraindications to cardiovascular magnetic resonance imaging



Age minimum: 6 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Muscular Dystrophies
Myocardial Fibrosis
Intervention(s)
Drug: Enalapril
Primary Outcome(s)
Quantitative Myocardial Fibrosis by CMR in patients with and without ACE inhibitor therapy [Time Frame: 2 years]
Secondary Outcome(s)
Specific genetic mutations as predictors of cardiac involvement [Time Frame: 2 years]
Secondary ID(s)
1095/08
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Sao Paulo
Federal University of Minas Gerais
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history